Cancer BiologyEuropean Journal of PharmacologyPeer-reviewed
Blocking Orai1 constitutive activity inhibits B-cell cancer migration and synergistically acts with drugs to reduce B-CLL cell survival
Julien Scaviner, Cristina Bagacean, Christian Berthou…·Souleymane Abdoul‐Azize
This study shows that inhibiting Orai1 reduces B-CLL cell survival and migration, and synergizes with existing drugs to enhance therapeutic effects.
4 citations